Form D SEC Filing: Confluence Pharmaceuticals $1.30 million Financing. Steven L Johns Submitted Nov 7 D Form

Pharmaceuticals Confluence Pharmaceuticals Llc - Steven L Johns

Confluence Pharmaceuticals Financing

Confluence Pharmaceuticals Llc, Limited Liability Company just filed form D for $1.30 million equity financing. This is a new filing. Confluence Pharmaceuticals was able to sell $1.28 million. That is 98.85% of the fundraising. The total offering amount was $1.30 million. The fundraising form was filed on 2016-11-07. The reason for the financing was: unspecified. The fundraising still has about $15,002 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Confluence Pharmaceuticals is based in Indiana. The filler’s business is Pharmaceuticals. The D form was signed by Steven L Johns President and Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 4904 Deer Ridge Drive South, Carmel, In, Indiana, 46033. Steven L. Johns is the related person in the form and it has address: 4904 Deer Ridge Drive South, Carmel, In, Indiana, 46033. Link to Confluence Pharmaceuticals Filing: 000168904816000001.

Analysis of Confluence Pharmaceuticals Offering

On average, firms in the Pharmaceuticals sector, sell 60.90% of the total offering size. Confluence Pharmaceuticals sold 98.85% of the offering. The financing is still open. Could this mean that the trust in Confluence Pharmaceuticals is high? The average offering amount for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 131.11% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this fundraising was set at $25000. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Confluence Pharmaceuticals Also

The Form D signed by Steven L Johns might help Confluence Pharmaceuticals Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment